These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

373 related articles for article (PubMed ID: 22862941)

  • 1. Generating an iPSC bank for HLA-matched tissue transplantation based on known donor and recipient HLA types.
    Taylor CJ; Peacock S; Chaudhry AN; Bradley JA; Bolton EM
    Cell Stem Cell; 2012 Aug; 11(2):147-52. PubMed ID: 22862941
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Do human leukocyte antigen-typed cellular therapeutics based on induced pluripotent stem cells make commercial sense?
    Bravery CA
    Stem Cells Dev; 2015 Jan; 24(1):1-10. PubMed ID: 25244598
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of human leukocyte antigen matching in the development of multiethnic "haplobank" of induced pluripotent stem cell lines.
    Gourraud PA; Gilson L; Girard M; Peschanski M
    Stem Cells; 2012 Feb; 30(2):180-6. PubMed ID: 22045598
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Haplotype-based banking of human pluripotent stem cells for transplantation: potential and limitations.
    Zimmermann A; Preynat-Seauve O; Tiercy JM; Krause KH; Villard J
    Stem Cells Dev; 2012 Sep; 21(13):2364-73. PubMed ID: 22559254
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Banking on iPSC--is it doable and is it worthwhile.
    Solomon S; Pitossi F; Rao MS
    Stem Cell Rev Rep; 2015 Feb; 11(1):1-10. PubMed ID: 25516409
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Proceedings: human leukocyte antigen haplo-homozygous induced pluripotent stem cell haplobank modeled after the california population: evaluating matching in a multiethnic and admixed population.
    Pappas DJ; Gourraud PA; Le Gall C; Laurent J; Trounson A; DeWitt N; Talib S
    Stem Cells Transl Med; 2015 May; 4(5):413-8. PubMed ID: 25926330
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Repurposing the Cord Blood Bank for Haplobanking of HLA-Homozygous iPSCs and Their Usefulness to Multiple Populations.
    Lee S; Huh JY; Turner DM; Lee S; Robinson J; Stein JE; Shim SH; Hong CP; Kang MS; Nakagawa M; Kaneko S; Nakanishi M; Rao MS; Kurtz A; Stacey GN; Marsh SGE; Turner ML; Song J
    Stem Cells; 2018 Oct; 36(10):1552-1566. PubMed ID: 30004605
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lack of T Cell Response to iPSC-Derived Retinal Pigment Epithelial Cells from HLA Homozygous Donors.
    Sugita S; Iwasaki Y; Makabe K; Kimura T; Futagami T; Suegami S; Takahashi M
    Stem Cell Reports; 2016 Oct; 7(4):619-634. PubMed ID: 27641646
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recent progress of national banking project on homozygous HLA-typed induced pluripotent stem cells in South Korea.
    Rim YA; Park N; Nam Y; Ham DS; Kim JW; Ha HY; Jung JW; Jung SM; Baek IC; Kim SY; Kim TG; Song J; Lee J; Park SH; Chung NG; Yoon KH; Ju JH
    J Tissue Eng Regen Med; 2018 Mar; 12(3):e1531-e1536. PubMed ID: 28941241
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development of immunocompatible pluripotent stem cells via CRISPR-based human leukocyte antigen engineering.
    Jang Y; Choi J; Park N; Kang J; Kim M; Kim Y; Ju JH
    Exp Mol Med; 2019 Jan; 51(1):1-11. PubMed ID: 30617277
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of human leucocyte antigen mismatch on graft-versus-host disease and graft failure after reduced intensity conditioning allogeneic haematopoietic stem cell transplantation from related donors.
    Teshima T; Matsuo K; Matsue K; Kawano F; Taniguchi S; Hara M; Hatanaka K; Tanimoto M; Harada M; Nakao S; Abe Y; Wake A; Eto T; Takemoto Y; Imamura M; Takahashi S; Ishida Y; Kanda Y; Kasai M; Takaue Y
    Br J Haematol; 2005 Aug; 130(4):575-87. PubMed ID: 16098073
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Haplobanking induced pluripotent stem cells for clinical use.
    Sullivan S; Fairchild PJ; Marsh SGE; Müller CR; Turner ML; Song J; Turner D
    Stem Cell Res; 2020 Dec; 49():102035. PubMed ID: 33221677
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of pretransplant donor anti-recipient cytotoxic and helper T lymphocyte responses as correlates of acute graft-vs.-host disease and survival after unrelated marrow transplantation.
    Pei J; Martin PJ; Longton G; Masewicz S; Mickelson E; Petersdorf E; Anasetti C; Hansen J
    Biol Blood Marrow Transplant; 1997 Aug; 3(3):142-9. PubMed ID: 9310191
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Selection of unrelated donors for hematopoietic cell transplantation.
    Field T; Anasetti C
    Curr Hematol Rep; 2005 Jul; 4(4):270-5. PubMed ID: 16009041
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunological considerations for embryonic and induced pluripotent stem cell banking.
    Taylor CJ; Bolton EM; Bradley JA
    Philos Trans R Soc Lond B Biol Sci; 2011 Aug; 366(1575):2312-22. PubMed ID: 21727137
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of HLA incompatibility in marrow transplantation from unrelated and HLA-mismatched related donors.
    Anasetti C; Hansen JA
    Transfus Sci; 1994 Sep; 15(3):221-30. PubMed ID: 10155543
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Significance of confirmatory testing of HLA system in unrelated haematopoietic stem cell donors].
    Dobrovolná M; Vraná M; Brdicka R; Loudová M
    Cas Lek Cesk; 2006; 145(1):32-5. PubMed ID: 16468239
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cardiomyocytes Derived from MHC-Homozygous Induced Pluripotent Stem Cells Exhibit Reduced Allogeneic Immunogenicity in MHC-Matched Non-human Primates.
    Kawamura T; Miyagawa S; Fukushima S; Maeda A; Kashiyama N; Kawamura A; Miki K; Okita K; Yoshida Y; Shiina T; Ogasawara K; Miyagawa S; Toda K; Okuyama H; Sawa Y
    Stem Cell Reports; 2016 Mar; 6(3):312-20. PubMed ID: 26905198
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Graft rejection and hyperacute graft-versus-host disease in stem cell transplantation from non-inherited maternal-antigen-complementary HLA-mismatched siblings.
    Okumura H; Yamaguchi M; Kotani T; Sugimori N; Sugimori C; Ozaki J; Kondo Y; Yamazaki H; Chuhjo T; Takami A; Ueda M; Ohtake S; Nakao S
    Eur J Haematol; 2007 Feb; 78(2):157-60. PubMed ID: 17313562
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High resolution HLA class I and II typing and CTLp frequency in unrelated donor transplantation: a single-institution retrospective study of 69 BMTs.
    El Kassar N; Legouvello S; Joseph CM; Salesses P; Rieux C; Cordonnier C; Vernant JP; Farcet JP; Bierling P; Kuentz M
    Bone Marrow Transplant; 2001 Jan; 27(1):35-43. PubMed ID: 11244436
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.